Telix Supports Molecular Imaging Summer Program at MSKCC
February 14 2020 – Telix Pharmaceuticals Ltd is pleased to announce our support of the Molecular Imaging Summer Program at MSKCC
Telix Pharmaceuticals Limited is excited to support an Australian undergraduate student to join the Student Molecular Imaging Summer Program (MISP) at Memorial Sloan Kettering Cancer Centre.
The Molecular Imaging Summer Program offers undergraduate students hands-on research experience in cutting-edge laboratories and the opportunity to interact with research and clinical faculty and trainees.
Over the last few years, we have been extremely lucky to have two high-quality candidates on the program and look forward to working with this year’s winner to expand the medical knowledge and experience in the field of molecular imaging.
The application deadline for Australian candidates has been extended to 28th Feb 2020. Please email your inquiries to email@example.com.
Further information about this exciting opportunity can be found here.